Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 143 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of General Medical Sciences
Grant: GM104306, GM119197, T32 GM108554-05, GM12171, K08 GM123345 , T32 GM007347-41
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Grant: AI151210
NIGMS NIH HHS
Grant: R01 GM119197
NIGMS NIH HHS
Grant: T32 GM152284
NIAID NIH HHS
Grant: R01 AI151210
NIGMS NIH HHS
Grant: R01 GM104306
NIGMS NIH HHS
Grant: K08 GM123345
NIGMS NIH HHS
Grant: T32 GM007347
NIGMS NIH HHS
Grant: T32 GM108554
National Institutes of Health
Grant: 1K08GM123345-01A1
Enhancement of Innate Anti-Microbial Immunity Using Novel Synthetic TLR4 Agonists
National Institutes of Health
Grant: 5R01AI151210-03
Macrophage mitochodrial reprogramming and innate immune memory
National Institutes of Health
Grant: 5R01GM119197-04
Training innate immunity: A new approach to the treatment of sepsis
National Institutes of Health
Grant: 2T32GM108554-07
TIPS: Training in Perioperative Science
National Institutes of Health
Grant: 5T32GM007347-08
MEDICAL SCIENTIST TRAINING PROGRAM
National Institutes of Health
Grant: 6R01GM104306-04
Augmentation of Innate Anti-Microbial Immunity by TLR4 Agonists
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals